Suppr超能文献

巢蛋白在恶性黑素瘤患者中的预后意义。

Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.

机构信息

Department of Dermatology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan.

出版信息

Eur J Dermatol. 2010 May-Jun;20(3):283-8. doi: 10.1684/ejd.2010.0909. Epub 2010 Feb 15.

Abstract

Nestin is an intermediate filament protein, and serves as a hair follicle stem cell and neural stem cell marker. Recent studies have suggested that nestin expression is also important for tumorigenesis. Previous reports from our laboratory have revealed that nestin is a marker of HMB-45-negative melanoma cells in dermal invasive lesions of nodular malignant melanoma. The present study examines nestin expression in malignant melanoma and investigates the relationship between nestin expression and prognosis in patients. We immunohistochemically stained 78 formalin-fixed and paraffin-embedded malignant melanomas for nestin, HMB-45 and S100 reactivity. We found that nestin, HMB-45 and S100 protein were detected in 56.5%, 88.4% and 100% of malignant melanomas, respectively. The 5-year survival rate of stage I and II nestin-positive cases was significantly decreased compared to the nestin-negative cases (p < 0.05). In addition, the 5-year survival rate exceeded 80% in nestin-negative malignant melanomas at all stages of tumor development. We conclude that nestin expression may be a predictor of poor prognosis in patients with malignant melanoma.

摘要

巢蛋白是一种中间丝蛋白,作为毛囊干细胞和神经干细胞的标志物。最近的研究表明,巢蛋白的表达对于肿瘤发生也很重要。我们实验室之前的报告显示,巢蛋白是结节性恶性黑素瘤皮肤浸润性病变中 HMB-45 阴性黑素瘤细胞的标志物。本研究检测了巢蛋白在恶性黑色素瘤中的表达,并探讨了巢蛋白表达与患者预后的关系。我们用免疫组织化学方法对 78 例福尔马林固定、石蜡包埋的恶性黑素瘤进行巢蛋白、HMB-45 和 S100 反应性染色。结果发现,巢蛋白、HMB-45 和 S100 蛋白在恶性黑素瘤中的检出率分别为 56.5%、88.4%和 100%。Ⅰ期和Ⅱ期巢蛋白阳性病例的 5 年生存率明显低于巢蛋白阴性病例(p<0.05)。此外,在肿瘤发展的各个阶段,巢蛋白阴性的恶性黑素瘤的 5 年生存率均超过 80%。我们的结论是,巢蛋白表达可能是恶性黑素瘤患者预后不良的预测指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验